DNMT3A and acute myeloid leukemia: A greater number of paediatric patients present with de novo AML than in adults and rarely have the common adult mutations such as DNMT3A and TET2 [5] suggesting that a difference in clonal heterogeneity between adult and paediatric cases may be explained by the genetic mutations.